Breaking News
Get 40% Off 0
🤯 Perficient is up a mind-blowing 53%. Our ProPicks AI saw the buying opportunity in March. Read full update
Close

Bristol Myers Squibb Co Rights (BMY_r)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Follow Bristol Myers Rights's earnings

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Bristol Myers Rights historical data, for real-time data please try another search
0.6901 0.0000    0.00%
31/12 - Closed. Currency in USD ( Disclaimer )
Type:  Equity
Market:  United States
  • Volume: 0
  • Bid/Ask: 0.5000 / 0.5100
  • Day's Range: 0.6100 - 0.8203
Bristol Myers Rights 0.6901 0.0000 0.00%

NYSE:BMY_r Financials

 
A brief overview of the NYSE:BMY_r financials. This summary provides an overview of the most significant critical numbers from each of its financial reports, including the income statement, balance sheet, and cash flow statement. Additionally, it features several financial ratios that provide insight into the company's financial health. Users can select to view data from four periods of either annual or quarterly information, allowing them to track financial performance of Bristol Myers Squibb Co Rights over time.

Bristol-Myers Squibb Company reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported sales was USD 306 million compared to USD 289 million a year ago. Revenue was USD 11,865 million compared to USD 11,337 million a year ago. Net loss was USD 11,911 million compared to net income of USD 2,262 million a year ago. Basic loss per share from continuing operations was USD 5.89 compared to basic earnings per share from continuing operations of USD 1.08 a year ago. Diluted loss per share from continuing operations was USD 5.89 compared to diluted earnings per share from continuing operations of USD 1.07 a year ago.

AnnualQuarterly  
Advanced Financial Summary
TTM = Trailing Twelve Months
MRQ = Most Recent Quarter

BMY_r Income Statement

Gross margin TTM -
Operating margin TTM -
Net Profit margin TTM -
Return on Investment TTM -
 Total Revenue  Net Income
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Revenue 11865 11477 10966 11226
Gross Profit 8955 8770 8476 8417
Operating Income 2284 1952 2104 1994
Net Income -11911 1762 1928 2073

BMY_r Balance Sheet

Quick Ratio MRQ -
Current Ratio MRQ -
LT Debt to Equity MRQ -
Total Debt to Equity MRQ -
 Total Assets  Total Liabilities
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Total Assets 99031 95159 91263 93489
Total Liabilities 82483 65674 62201 61459
Total Equity 16548 29485 29062 32030

BMY_r Cash Flow Statement

Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow  10.98%
 Cash  Net Change in Cash
Period Ending: Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023
Period Length: 0 Months 0 Months 0 Months 0 Months
Cash From Operating Activities 2834 4252 4751 1887
Cash From Investing Activities -19618 -1346 -410 -329
Cash From Financing Activities 14644 967 -5160 -2173
Net Change in Cash -2185 3951 -857 -623
* In Millions of USD (except for per share items)
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced insights on financial statements, including growth rates and metrics that provide an in-depth view of the company's historical and forecasted financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

BMY_r Comments

Write your thoughts about Bristol Myers Squibb Co Rights
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
usa forever
usa forever Jan 07, 2021 10:47PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
market just delisted these stocks.. ***..
Pankaj Negi
Pankaj Negi Jan 07, 2021 9:56PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
hey guys the money in this one is gone evaporated all.there vaccines didn't get fda approval
usa forever
usa forever Jan 07, 2021 2:09PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
just wait for one big guts investors to shoot the moon for these stocks..and it will be raining on the summer time.the question is, who is the investors?Lmao
Ishtiaq Bokhari
Ishtiaq Bokhari Jan 05, 2021 2:27PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
interesting day the today certification of the Georgia works and this situation I think I kind of request Mr Trump that enough is enough you had your turn to play the long run it's good next time you be strong or heavier just try it if they prove it wrong you already prove it so that would be very recall of the government that can brought it up that point if they cannot produce to the primary but this is a different anomaly and you're sitting to the Moon string
Ishtiaq Bokhari
Ishtiaq Bokhari Jan 05, 2021 2:26PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
is it Mr Meyer and Scott or is another like
Shakib Imtiaz
Shakib Imtiaz Jan 04, 2021 3:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Jamal Khan
Jamal Khan Jan 04, 2021 2:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Why is it halted?
Jamal Khan
Jamal Khan Jan 04, 2021 2:45PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
What happened?
Hamza Khan
Hamza Khan Jan 02, 2021 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
why did this stock drop in the 5th ?
Hamza Khan
Hamza Khan Jan 02, 2021 2:13PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
on the 5th november 2020
Doan Tungy
Doan Tungy Dec 31, 2020 9:27AM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
whattt... Is happening?
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email